C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms

Patents for C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
10/2007
10/24/2007	CN101061095A Cycloalkyl piperidine tachykinin receptor antagonists
10/18/2007	WO2007117565A2 Standardization of processes for culturing primary cells
10/10/2007	CN100341870C Glycosidase inhibitors and preparation thereof
09/2007
09/20/2007	US20070219375 Novel Compound and Organic Electronic Device Using the Same
08/2007
08/23/2007	US20070197494 Photosensitisers and their uses
08/23/2007	US20070197493 Selenophene anti-tumor agents
08/15/2007	EP1817312A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
08/15/2007	EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists
07/2007
07/25/2007	CN101003525A Dicationic compounds which selectively recognize G-quadruplex DNA
07/18/2007	EP1807077A2 Inhibitors of c-fms kinase
06/2007
06/06/2007	EP1792613A2 Dicationic compounds which selectively recognize G-quadruplex DNA
05/2007
05/02/2007	EP1780209A1 Oxime ester compound and photopolymerization initiator containing such compound
04/2007
04/17/2007	US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions
04/10/2007	US7202363 Thienopyridine and furopyridine kinase inhibitors
03/2007
03/28/2007	CN1935797A Novel bichalcophenes and their prodrugs as antiprotozoal agents
03/27/2007	US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/08/2007	US20070054899 Aromatase inhibitor compounds and uses thereof
03/07/2007	EP1760058A1 Single crystal, material for nanowiring, electronic device, and process for producing material for nanowiring
03/01/2007	WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors
01/2007
01/23/2007	US7166715 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
12/2006
12/27/2006	CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
12/14/2006	WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists
12/07/2006	WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
11/2006
11/29/2006	EP1726589A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP0896972B1 Method for producing a selenized transparent optical material
11/20/2006	CA2547186A1 Novel biochalcophenes and their prodrugs as antiprotozoal agents
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
10/2006
10/24/2006	US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds
10/10/2006	US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same
09/2006
09/19/2006	CA2255664C Selenophene anti-tumor agents
09/14/2006	WO2006094645A1 Monomers, oligomers and polymers comprising thiophene and selenophene
09/08/2006	WO2005086700A3 Hiv integrase inhibitors
08/2006
08/17/2006	US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
07/2006
07/27/2006	WO2006026033A3 Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy
07/19/2006	CN1805955A Oxime ester compound and photopolymerization initiator containing such compound
07/13/2006	CA2587195A1 Cycloalkyl keto piperidine tachykinin receptor antagonists
07/12/2006	EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
07/04/2006	US7071209 Cyclization while heating in solvent in presence of strong acid; methylation in presence of a base; purity
06/2006
06/22/2006	US20060135569 Use of benzisoselenazolone compounds against ischemic myocardial damage
06/13/2006	US7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
06/07/2006	EP1448577B1 Rhodium and iridium complexes
06/01/2006	WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/01/2006	CA2587256A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
06/01/2006	CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists
04/2006
04/11/2006	US7026476 Intermediate arylamine compounds
03/2006
03/07/2006	US7008950 For example 3-(4-Isopropylphenyl)-5-(4-methoxybenzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran and its synthesis; suppress cell toxicities caused by beta-amyloid protein, protect nerve cells
02/2006
02/23/2006	WO2006018973A1 Oxime ester compound and photopolymerization initiator containing such compound
12/2005
12/29/2005	WO2005123637A1 Single crystal, material for nanowiring, electronic device, and process for producing material for nanowiring
12/21/2005	EP1606290A1 Weak base salts
11/2005
11/29/2005	CA2318160C Asymmetric cyanine dye quenchers
11/03/2005	WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/02/2005	CN1690057A Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
10/2005
10/26/2005	EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
10/13/2005	US20050227293 Styryl dyes with linker
09/2005
09/22/2005	CA2557904A1 Hiv integrase inhibitors
09/15/2005	US20050203077 Selenophene anti-tumor agents
08/2005
08/11/2005	US20050176958 Rhodium and iridium complexes
08/03/2005	EP1438307B1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
06/2005
06/15/2005	EP1541145A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
05/2005
05/17/2005	US6894039 A selenium containing heterocyclic compounds that are analogs of naturally occurring thiophene, furan and pyrrole, has cytotoxic effect, use as anticarcinogenic agents
04/2005
04/14/2005	WO2005033104A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
04/14/2005	CA2540502A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
04/13/2005	CN1196701C Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides
03/2005
03/30/2005	CN1602313A 铑和铱的络合物 Complexes of rhodium and iridium
02/2005
02/02/2005	CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
01/2005
01/13/2005	US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
12/2004
12/15/2004	EP1337520B1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
11/2004
11/24/2004	EP1478634A1 Furanone derivatives
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/09/2004	US6815459 Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
09/2004
09/23/2004	WO2004081006A1 Weak base salts
09/23/2004	CA2515289A1 Weak base salts
08/2004
08/25/2004	EP1448577A1 Rhodium and iridium complexes
07/2004
07/21/2004	EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
07/07/2004	CN1156461C Improved aqueous solubility pharmaceutical formulations
06/2004
06/15/2004	US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
05/2004
05/19/2004	EP0970078B1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
04/2004
04/01/2004	US20040063662 Selective cytotoxicity for slow growing abnormal cells
12/2003
12/31/2003	WO2004000309A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
12/31/2003	CN1463972A Novel N-substituted pyridine Benzisoxazolone compound, method for making same and its pharmaceutical composition and use thereof
12/31/2003	CA2493865A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
12/23/2003	US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/16/2003	US6664364 Selenium-containing transparent optical material
11/2003
11/27/2003	US20030220337 Use in preventing various medical dysfunctions and diseases arising from reactive oxygen species, in particular stroke, Parkinson's disease, Alzheimer's disease; lipid peroxidation inhibition activity
11/06/2003	US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
10/2003
10/09/2003	US20030191104 Therapy for carbohydrate metabolism disorders
10/07/2003	CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
09/2003
09/18/2003	US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/16/2003	US6620804 Selenophene anti-tumor agents
09/04/2003	WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
09/04/2003	US20030166830 Selenium-containing transparent optical material
09/04/2003	US20030166672 Derivatives of 4-(Thio- or Selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
08/2003
08/28/2003	US20030162775 Heterocyclic substituted pyrazolones
08/27/2003	EP1337520A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
08/27/2003	EP1021178B1 Selenophene anti-tumor agents
08/07/2003	WO2003064403A1 Furanone derivatives
08/07/2003	CA2474871A1 Furanone derivatives
07/2003
07/23/2003	CN1431904A Protease inhitors

1 2 3 4 5